'What Ifs' for America's Research Consortia

Perhaps at no time since the Second World War has there been such an emphasis on the rapid transfer of research findings to development. The 1980s have seen the birth of dozens of research consortia designed to quicken the pace of technological development in the United States. Coming from a wide array of businesses and varied academic institutions, these R&D consortia are seen by many as the answer to the United States' regaining the lead it has lost in technological competitiveness. In The New

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

What are the prospects? Marc Tucker [director of the Carnegie Forum in Washington, D.C.] views the advent of research and development consortia with a cool dose of practicality. "If you were to look at these consortia as the principal instrument for adjusting to the problems that we face economically, I would have to say: 'Ridiculous.' They don't begin to get at the larger problems that we face. On their own terms, though, they are incredibly valuable contributions." His observation opens the question of whether the scale of the response represented by industry-university consortia is commensurate with the sense of threat to survival felt by American industry.

The first answer, then, to the "what if' question is that more consortia, properly capitalized and led, could well serve to accelerate the move toward a national technology agenda. This raises immediate questions of national policy. Should the federal government—following the recent lead of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Dan Dimancescu

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours